SMARCA2 - SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 101925399
SMARCA2 Products (15)
| mRNA | Protein | Name |
|---|---|---|
| XM_045373182.1 | XP_045229117.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373183.1 | XP_045229118.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373178.1 | XP_045229113.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373176.1 | XP_045229111.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373184.1 | XP_045229119.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373179.1 | XP_045229114.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373181.1 | XP_045229116.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373180.1 | XP_045229115.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373175.1 | XP_045229110.1 | probable global transcription activator SNF2L2 isoform X1 |
| XM_045373186.1 | XP_045229121.1 | probable global transcription activator SNF2L2 isoform X3 |
| XM_045373185.1 | XP_045229120.1 | probable global transcription activator SNF2L2 isoform X2 |
| XM_045373191.1 | XP_045229126.1 | probable global transcription activator SNF2L2 isoform X5 |
| XM_045373187.1 | XP_045229122.1 | probable global transcription activator SNF2L2 isoform X4 |
| XM_045373190.1 | XP_045229125.1 | probable global transcription activator SNF2L2 isoform X4 |
| XM_045373189.1 | XP_045229124.1 | probable global transcription activator SNF2L2 isoform X4 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
probable global transcription activator SNF2L2 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-159607 | PRT3789 | Degrader | 98.08% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(33)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-145388 | AU-15330 | Degrader | 99.89% | Unkown |
| HY-128359 | ACBI1 | Degrader | 99.92% | Unkown |
| HY-44012 | SMARCA-BD ligand 1 for PROTAC | Ligand | 99.07% | Unkown |
| HY-44012B | SMARCA-BD ligand 1 for PROTAC hydrochloride | Ligand | 99.24% | Unkown |
| HY-44012A | SMARCA-BD ligand 1 for PROTAC dihydrochloride | Ligand | 98.08% | Unkown |
| HY-46618 | SMARCA2/4-ligand-8 | Ligand | / | Unkown |
| HY-170824 | SMD-3236 | Degrader | / | Unkown |
| HY-185075 | FHD-909 | Inhibitor | / | Unkown |
| HY-168237 | SMARCA2 ligand-10 | Ligand | / | Unkown |
| HY-162814 | SMARCA2/4-ligand-3 | Ligand | / | Unkown |
| HY-169280 | PXR Ligand 2 | / | Unkown | |
| HY-170354 | SMARCA2/4-ligand-4 | Ligand | / | Unkown |
| HY-161885 | SMARCA2/4-IN-4 | Inhibitor | / | Unkown |
| HY-170349 | SMARCA2 ligand-11 | Ligand | / | Unkown |
| HY-163949 | SMARCA2/4-IN-3 | Inhibitor | / | Unkown |
| HY-44824 | SMARCA2 ligand-13 | Ligand | / | Unkown |
| HY-180960 | NEP202 | Degrader | / | Unkown |
| HY-171765 | SMARCA2/4-ligand-6 | Ligand | / | Unkown |
| HY-178225 | PROTAC SMARCA2/4 degrader-39 | Degrader | / | Unkown |
| HY-168248 | BRM/BRG1 ligand 2 | Ligand | / | Unkown |
| HY-181909 | PROTAC SMARCA2 degrader-36 | Degrader | / | Unkown |
| HY-153425 | PROTAC SMARCA2/4 degrader-41 | Degrader | / | Unkown |
| HY-168230 | SMARCA2 ligand-9 | Ligand | / | Unkown |
| HY-180931 | PROTAC A515 | Degrader | / | Unkown |
| HY-170817 | SMI-1074 | Inhibitor | / | Unkown |
| HY-181910 | SMARCA2 ligand-19 | Ligand | / | Unkown |
| HY-169487 | SMARCA2 ligand-12 | / | Unkown | |
| HY-180932 | SMARCA2 ligand-17 | Ligand | / | Unkown |
| HY-176871 | PROTAC SMARCA2 degrader-35 | Degrader | / | Unkown |
| HY-168252 | BRM/BRG1 ligand 3 | Ligand | / | Unkown |
| HY-172446 | SMARCA2/4-ligand-5 | / | Unkown | |
| HY-159472 | SMARCA2/4-ligand-1 | Inhibitor | / | Unkown |
| HY-W539427 | BRM/BRG1 ligand 1 | Ligand | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service